European tech funding raised by Switzerland startups during Q3 2020.
In Q3 2020, 57 startups in Switzerland raised a combined €539M across 58 funding rounds, up 27.2% versus Q3 2019. Healthtech was the most active sector, and Alpana Ventures was the most active investor. Data as of 9 Jul 2026.
4 exits · €85M disclosed.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Sophia Genetics | Series D+ | Sep 2020 | €94M |
| Climeworks | Other | Sep 2020 | €93M |
| Carvolution | Series B | Sep 2020 | €46M |
| Vectivbio | Series A | Aug 2020 |
| Acquisition |
| Aug 2020 |
| €85M |
| €29M |
| T3 Pharmaceuticals | Other | Jul 2020 | €23M |
| NBE-Therapeutics | Other | Sep 2020 | €21M |
| Numab | Series B | Sep 2020 | €20M |
| NBE-Therapeutics | Series C | Sep 2020 | €19M |
| BioVersys | Series B | Aug 2020 | €18M |
| Numbrs | Series B | Sep 2020 | €16M |
| Metaco | Series A | Jul 2020 | €15M |
| Advertima | Series A | Jul 2020 | €15M |
| Polyneuron Pharmaceuticals AG | Series A | Sep 2020 | €13M |
| Yamo | Series A | Jul 2020 | €10M |
| Bloom Diagnostics | Series B | Aug 2020 | €10M |
